COVID-19 impact on an oncologic emergency department visits: observational study.
Aurélie RamArnaud PagèsEdouard CubilierNesrine DaoudiFrederic VandergheynstFlorian ScotteSami AntounMansouriah MeradPublished in: BMJ supportive & palliative care (2023)
Our study shows that ED visits during the first wave of the COVID-19 pandemic remained stable for our patients regardless of the symptom's severity. The fear of an in-hospital viral contamination appears weaker than the need for pain management or for the treatment of cancer-related complications. This study highlights the positive impact of cancer ED in the first-line treatment and supportive care of patients with cancer.
Keyphrases
- emergency department
- pain management
- sars cov
- healthcare
- end stage renal disease
- coronavirus disease
- chronic kidney disease
- newly diagnosed
- palliative care
- prostate cancer
- chronic pain
- risk assessment
- squamous cell carcinoma
- peritoneal dialysis
- papillary thyroid
- adverse drug
- patient reported outcomes
- health risk
- young adults
- patient reported
- squamous cell
- minimally invasive
- lymph node metastasis
- childhood cancer